Moreover, several studies have shown that the inhibition of NOX1 and NOX4 leads to decreased oxidative stress, lipid peroxidation, hepatic injury, inflammation, and fibrosis in NASH [108,109]. The gene discussed is NOX4; the disease is metabolic dysfunction-associated steatohepatitis.